Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the European …
Canaccord Genuity analyst Neil Maruoka came out today with a research note on Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), after the company released its fourth-quarter results, posting a net loss …